Hormonal treatments and migraine characteristics across reproductive stages and transition to menopause: A cross-sectional study.

Hormonal treatments (HTs) are commonly used by women for various reasons. This study looked at how HTs affect migraines in women. Researchers focused on women aged 18-60 with migraines. They wanted to understand HT use, migraine characteristics, and related symptoms. The study involved a survey about HT types, reproductive status, and symptoms. Participants included women using combined oral contraceptives, progestogen-only pills, and hormonal intrauterine devices. Only women who had been using these treatments for at least three months were included. The researchers aimed to compare migraine experiences between HT users and nonusers. They also investigated how menstrual and menopause symptoms varied among these groups. Understanding these differences can help improve treatment options for women dealing with migraines. This research highlights the importance of considering hormonal factors when treating female migraine patients. Clinical relevance: This study indicates that hormonal treatments may influence migraine characteristics, guiding personalized treatment strategies for women experiencing migraines during different reproductive stages.